位置:首页 > 蛋白库 > A1LB1_LOXAR
A1LB1_LOXAR
ID   A1LB1_LOXAR             Reviewed;         309 AA.
AC   Q4ZFU2;
DT   06-MAR-2007, integrated into UniProtKB/Swiss-Prot.
DT   07-JUN-2005, sequence version 1.
DT   03-AUG-2022, entry version 66.
DE   RecName: Full=Dermonecrotic toxin LarSicTox-alphaIB2bi {ECO:0000303|PubMed:25752604};
DE            EC=4.6.1.- {ECO:0000269|PubMed:24009677, ECO:0000269|PubMed:25752604};
DE   AltName: Full=Laz-SMase D;
DE   AltName: Full=Phospholipase D;
DE            Short=PLD;
DE   AltName: Full=Sphingomyelin phosphodiesterase D 2;
DE            Short=SMD 2;
DE            Short=SMase D 2;
DE            Short=Sphingomyelinase D 2;
DE   Flags: Precursor; Fragment;
OS   Loxosceles arizonica (Arizona brown spider).
OC   Eukaryota; Metazoa; Ecdysozoa; Arthropoda; Chelicerata; Arachnida; Araneae;
OC   Araneomorphae; Haplogynae; Scytodoidea; Sicariidae; Loxosceles.
OX   NCBI_TaxID=196454;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Venom gland;
RX   PubMed=15777950; DOI=10.1016/j.toxicon.2004.11.011;
RA   Binford G.J., Cordes M.H.J., Wells M.A.;
RT   "Sphingomyelinase D from venoms of Loxosceles spiders: evolutionary
RT   insights from cDNA sequences and gene structure.";
RL   Toxicon 45:547-560(2005).
RN   [2]
RP   TOXIC DOSE, AND SUBCELLULAR LOCATION.
RX   PubMed=22561243; DOI=10.1016/j.toxicon.2012.04.350;
RA   Zobel-Thropp P.A., Kerins A.E., Binford G.J.;
RT   "Sphingomyelinase D in sicariid spider venom is a potent insecticidal
RT   toxin.";
RL   Toxicon 60:265-271(2012).
RN   [3]
RP   FUNCTION, CATALYTIC ACTIVITY, AND MUTAGENESIS OF HIS-74.
RX   PubMed=24009677; DOI=10.1371/journal.pone.0072372;
RA   Lajoie D.M., Zobel-Thropp P.A., Kumirov V.K., Bandarian V., Binford G.J.,
RA   Cordes M.H.;
RT   "Phospholipase D toxins of brown spider venom convert
RT   lysophosphatidylcholine and sphingomyelin to cyclic phosphates.";
RL   PLoS ONE 8:E72372-E72372(2013).
RN   [4]
RP   CATALYTIC ACTIVITY, AND FUNCTION.
RX   PubMed=25752604; DOI=10.1074/jbc.m115.636951;
RA   Lajoie D.M., Roberts S.A., Zobel-Thropp P.A., Delahaye J.L., Bandarian V.,
RA   Binford G.J., Cordes M.H.;
RT   "Variable substrate preference among phospholipase D toxins from Sicariid
RT   spiders.";
RL   J. Biol. Chem. 290:10994-11007(2015).
CC   -!- FUNCTION: Dermonecrotic toxins cleave the phosphodiester linkage
CC       between the phosphate and headgroup of certain phospholipids
CC       (sphingolipid and lysolipid substrates), forming an alcohol (often
CC       choline) and a cyclic phosphate (PubMed:24009677, PubMed:25752604).
CC       This toxin acts on sphingomyelin (SM) with high activity and on
CC       lysophosphatidylcholine (LPC) and ceramide phosphoethanolamine (CPE)
CC       with low activity (PubMed:24009677, PubMed:25752604). In vivo, shows
CC       potent insecticidal activities (PubMed:22561243). On mammals, induces
CC       dermonecrosis, hemolysis, increased vascular permeability, edema,
CC       inflammatory response, and platelet aggregation (By similarity).
CC       {ECO:0000250|UniProtKB:P0CE80, ECO:0000269|PubMed:22561243,
CC       ECO:0000269|PubMed:24009677, ECO:0000269|PubMed:25752604}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=an N-(acyl)-sphingosylphosphocholine = an N-(acyl)-sphingosyl-
CC         1,3-cyclic phosphate + choline; Xref=Rhea:RHEA:60652,
CC         ChEBI:CHEBI:15354, ChEBI:CHEBI:64583, ChEBI:CHEBI:143892;
CC         Evidence={ECO:0000269|PubMed:24009677, ECO:0000269|PubMed:25752604};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=N-hexanoyl-sphing-4-enine-1-phosphocholine = choline + N-
CC         (hexanoyl)-sphing-4-enine-1,3-cyclic phosphate; Xref=Rhea:RHEA:60620,
CC         ChEBI:CHEBI:15354, ChEBI:CHEBI:78254, ChEBI:CHEBI:143883;
CC         Evidence={ECO:0000269|PubMed:24009677, ECO:0000269|PubMed:25752604};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=N-(dodecanoyl)-sphing-4-enine-1-phosphocholine = choline + N-
CC         dodecanoyl-sphing-4-enine-1,3-cyclic phosphate; Xref=Rhea:RHEA:60636,
CC         ChEBI:CHEBI:15354, ChEBI:CHEBI:137334, ChEBI:CHEBI:143884;
CC         Evidence={ECO:0000269|PubMed:25752604};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=a 1-acyl-sn-glycero-3-phosphocholine = a 1-acyl-sn-glycero-
CC         2,3-cyclic phosphate + choline; Xref=Rhea:RHEA:60700,
CC         ChEBI:CHEBI:15354, ChEBI:CHEBI:58168, ChEBI:CHEBI:143947;
CC         Evidence={ECO:0000269|PubMed:24009677, ECO:0000269|PubMed:25752604};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=1-tetradecanoyl-sn-glycero-3-phosphocholine = 1-tetradecanoyl-
CC         sn-glycero-2,3-cyclic phosphate + choline; Xref=Rhea:RHEA:60604,
CC         ChEBI:CHEBI:15354, ChEBI:CHEBI:64489, ChEBI:CHEBI:143882;
CC         Evidence={ECO:0000269|PubMed:25752604};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=1-octanoyl-sn-glycero-3-phosphocholine = 1-octanoyl-sn-
CC         glycero-2,3-cyclic phosphate + choline; Xref=Rhea:RHEA:60612,
CC         ChEBI:CHEBI:15354, ChEBI:CHEBI:143866, ChEBI:CHEBI:143876;
CC         Evidence={ECO:0000269|PubMed:24009677, ECO:0000269|PubMed:25752604};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=1-hexadecanoyl-sn-glycero-3-phosphocholine = 1-hexadecanoyl-
CC         sn-glycero-2,3-cyclic phosphate + choline; Xref=Rhea:RHEA:60656,
CC         ChEBI:CHEBI:15354, ChEBI:CHEBI:72998, ChEBI:CHEBI:143893;
CC         Evidence={ECO:0000269|PubMed:24009677};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=an N-(acyl)-sphingosylphosphoethanolamine = an N-(acyl)-
CC         sphingosyl-1,3-cyclic phosphate + ethanolamine; Xref=Rhea:RHEA:60648,
CC         ChEBI:CHEBI:57603, ChEBI:CHEBI:143891, ChEBI:CHEBI:143892;
CC         Evidence={ECO:0000269|PubMed:25752604};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=N-dodecanoyl-heptadecasphing-4-enine-1-phosphoethanolamine =
CC         ethanolamine + N-dodecanoyl-heptadecasphing-4-enine-1,3-cyclic
CC         phosphate; Xref=Rhea:RHEA:60616, ChEBI:CHEBI:57603,
CC         ChEBI:CHEBI:143864, ChEBI:CHEBI:143865;
CC         Evidence={ECO:0000269|PubMed:25752604};
CC   -!- COFACTOR:
CC       Name=Mg(2+); Xref=ChEBI:CHEBI:18420;
CC         Evidence={ECO:0000250|UniProtKB:Q8I914};
CC       Note=Binds 1 Mg(2+) ion per subunit. {ECO:0000250|UniProtKB:Q8I914};
CC   -!- SUBCELLULAR LOCATION: Secreted {ECO:0000269|PubMed:22561243}.
CC   -!- TISSUE SPECIFICITY: Expressed by the venom gland.
CC       {ECO:0000305|PubMed:22561243}.
CC   -!- TOXIC DOSE: PD(50) is 2.27 +-0.43 ug/g when injected into cricket
CC       (Acheta domestica) (observed at 60 minutes).
CC       {ECO:0000269|PubMed:22561243}.
CC   -!- TOXIC DOSE: LD(50) is 2.27 +-0.43 ug/g when injected into cricket
CC       (Acheta domestica) (observed at 24 hours).
CC       {ECO:0000269|PubMed:22561243}.
CC   -!- SIMILARITY: Belongs to the arthropod phospholipase D family. Class II
CC       subfamily. {ECO:0000305}.
CC   -!- CAUTION: The most common activity assay for dermonecrotic toxins
CC       detects catalytic activity by monitoring choline release from
CC       substrate. Liberation of choline from sphingomyelin (SM) or
CC       lysophosphatidylcholine (LPC) is commonly assumed to result from
CC       substrate hydrolysis, giving either ceramide-1-phosphate (C1P) or
CC       lysophosphatidic acid (LPA), respectively, as a second product.
CC       However, two studies from Lajoie and colleagues (2013 and 2015) report
CC       the observation of exclusive formation of cyclic phosphate products as
CC       second products, resulting from intramolecular transphosphatidylation.
CC       Cyclic phosphates have vastly different biological properties from
CC       their monoester counterparts, and they may be relevant to the pathology
CC       of brown spider envenomation. {ECO:0000269|PubMed:24009677,
CC       ECO:0000269|PubMed:25752604}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AY699703; AAW22997.1; -; mRNA.
DR   AlphaFoldDB; Q4ZFU2; -.
DR   SMR; Q4ZFU2; -.
DR   SwissLipids; SLP:000001960; -.
DR   ArachnoServer; AS000135; Sphingomyelinase D (LaSicTox-alphaIB2bi).
DR   BRENDA; 3.1.4.41; 8289.
DR   GO; GO:0005576; C:extracellular region; IEA:UniProtKB-SubCell.
DR   GO; GO:0016829; F:lyase activity; IEA:UniProtKB-KW.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0008081; F:phosphoric diester hydrolase activity; IEA:InterPro.
DR   GO; GO:0090729; F:toxin activity; IEA:UniProtKB-KW.
DR   GO; GO:0044179; P:hemolysis in another organism; IEA:UniProtKB-KW.
DR   GO; GO:0016042; P:lipid catabolic process; IEA:UniProtKB-KW.
DR   Gene3D; 3.20.20.190; -; 1.
DR   InterPro; IPR017946; PLC-like_Pdiesterase_TIM-brl.
DR   SUPFAM; SSF51695; SSF51695; 1.
PE   1: Evidence at protein level;
KW   Cytolysis; Dermonecrotic toxin; Disulfide bond; Glycoprotein; Hemolysis;
KW   Lipid degradation; Lipid metabolism; Lyase; Magnesium; Metal-binding;
KW   Secreted; Signal; Toxin; Zymogen.
FT   SIGNAL          <1..1
FT                   /evidence="ECO:0000255"
FT   PROPEP          2..27
FT                   /evidence="ECO:0000250"
FT                   /id="PRO_0000279549"
FT   CHAIN           28..309
FT                   /note="Dermonecrotic toxin LarSicTox-alphaIB2bi"
FT                   /id="PRO_0000279550"
FT   ACT_SITE        38
FT                   /evidence="ECO:0000250|UniProtKB:Q8I914"
FT   ACT_SITE        74
FT                   /note="Nucleophile"
FT                   /evidence="ECO:0000250|UniProtKB:Q8I914"
FT   BINDING         58
FT                   /ligand="Mg(2+)"
FT                   /ligand_id="ChEBI:CHEBI:18420"
FT                   /evidence="ECO:0000250|UniProtKB:Q8I914"
FT   BINDING         60
FT                   /ligand="Mg(2+)"
FT                   /ligand_id="ChEBI:CHEBI:18420"
FT                   /evidence="ECO:0000250|UniProtKB:Q8I914"
FT   BINDING         118
FT                   /ligand="Mg(2+)"
FT                   /ligand_id="ChEBI:CHEBI:18420"
FT                   /evidence="ECO:0000250|UniProtKB:Q8I914"
FT   CARBOHYD        286
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   DISULFID        78..84
FT                   /evidence="ECO:0000250|UniProtKB:P0CE80"
FT   DISULFID        80..223
FT                   /evidence="ECO:0000250|UniProtKB:P0CE80"
FT   MUTAGEN         74
FT                   /note="H->N: Does not release choline from LPC."
FT                   /evidence="ECO:0000269|PubMed:24009677"
FT   NON_TER         1
SQ   SEQUENCE   309 AA;  35179 MW;  3BBB88FA597C7605 CRC64;
     VRATEKFAPI YFFCHPLQSA ETDVAERANK RPIWIMGHMV NANYQIDEFV NLGANSIETD
     VSFDSSANPE YTYHGVPCDC RRWCKKWEYF NNFLKALRKA TTPGDSKYHE KLVLVVFDLK
     TGSLYDNQAY DAGKKLAKNL LQHYWNNGNN GGRAYIVLSI PNLAHYKLIT GFKETLKTEG
     HPELMEKVGY DFSGNDNIDQ VANAYKKAGV TGHVWQSDGI TNCVASFIRG LDRAKKAVKN
     RDSSNGYINK VYYWTVDKYA TTREAFDIGV DGIMTNYPDV IANVLNESAY KGKFRLATYD
     DNPWETFKN
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024